Premium
P4‐551: VALIDATION OF A NEW ANTIBODY THAT RECOGNIZES A CONFORMATIONAL VARIANT OF P53 SPECIFIC FOR ALZHEIMER'S AT THE PRE‐CLINICAL AND PRODROMAL STAGES OF THE DISEASE
Author(s) -
Abate Giulia,
Vezzoli Marika,
Polito Letizia,
Guaita Antonio,
Memo Maurizio,
Fowler Christopher,
Cummings Jeffrey L.,
Uberti Daniela,
Group AIBL Research
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.08.098
Subject(s) - biomarker , cohort , clinical significance , medicine , disease , oncology , antibody , population , biology , immunology , biochemistry , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom